---
title: "Why Codexis Stock Is Falling After Hours Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293711759.md"
description: "Codexis (CDXS) shares plummeted over 20% in after-hours trading to $1.58 following the pricing of a discounted public offering. The company sold 16.7 million shares at $1.50 each, raising approximately $23.1 million for working capital and R&D. This price is significantly below Thursday's regular session close of $1.99, contributing to a sharp decline in stock value amid broader negative trends."
datetime: "2026-07-24T05:43:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293711759.md)
  - [en](https://longbridge.com/en/news/293711759.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293711759.md)
---

# Why Codexis Stock Is Falling After Hours Today

**Codexis Inc.** (NASDAQ:CDXS) shares fell sharply in Thursday’s after-hours trading after the biotechnology company priced an underwritten public offering of common stock.

Codexis shares closed Thursday’s regular session down 3.40% at $1.99 before falling another 20.60% in after-hours trading to $1.58.

The company develops enzymatic solutions used in the manufacturing of complex therapeutics, including RNA-based medicines, through its proprietary CodeEvolver® technology.

## Announcement of Public Offering

Codexis announced the pricing of an underwritten public offering of 16.7 million common shares at $1.50 per share, below Thursday’s closing price of $1.99. The company expects to raise approximately $23.1 million in net proceeds after underwriting discounts and offering expenses.

The company also granted the underwriters a 30-day option to purchase up to an additional 2.5M shares to cover over-allotments.

Codexis said it intends to use the proceeds for working capital and other general corporate purposes, including research, development and business activities.

**Read Also: Robin Energy Stock Falls After Hours: Here's Why**

## Trading Metrics

Codexis has a market capitalization of approximately $180.88 million, with a 52-week high of $3.87 and a 52-week low of $0.96.

Over the past 12 months, CDXS shares have declined approximately 38.58%.

**Benzinga Edge Stock Rankings** show negative price trends across the short-, medium- and long-term time frames.

**Read Also: Nvidia Partnership Gets Amkor Technology (AMKR) Stock Trending: Here's What You Should Know**

_Photo Courtesy: TIMS13 on Shutterstock.com_

### Related Stocks

- [CDXS.US](https://longbridge.com/en/quote/CDXS.US.md)
- [RBNE.US](https://longbridge.com/en/quote/RBNE.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [AMKR.US](https://longbridge.com/en/quote/AMKR.US.md)
- [RBNEV.US](https://longbridge.com/en/quote/RBNEV.US.md)
- [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md)

## Related News & Research

- [Codexis (NASDAQ:CDXS) Issues Earnings Results](https://longbridge.com/en/news/295586914.md)
- [Codexis Q2 net loss narrows, helped by lower operating expenses](https://longbridge.com/en/news/295574796.md)
- [CDXS: Q2 2026 saw improved margins and narrowed losses, with liquidity strengthened by a July public offering](https://longbridge.com/en/news/295576463.md)
- [Lakewood-Amedex Biotherapeutics announces annual shareholder meeting](https://longbridge.com/en/news/295452742.md)
- [Sodexo reports 147,454,887 shares outstanding, 216,593,858 voting rights as of July 31, 2026](https://longbridge.com/en/news/295125804.md)